Inspire Medical Systems Inc operates as a medical technology company... Show more
A.I.dvisor indicates that over the last year, INSP has been loosely correlated with VIVO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INSP jumps, then VIVO could also see price increases.
| Ticker / NAME | Correlation To INSP | 1D Price Change % | ||
|---|---|---|---|---|
| INSP | 100% | -3.68% | ||
| VIVO - INSP | 41% Loosely correlated | -12.16% | ||
| LIVN - INSP | 38% Loosely correlated | -1.16% | ||
| AZTA - INSP | 37% Loosely correlated | +0.26% | ||
| CSTL - INSP | 35% Loosely correlated | +0.37% | ||
| SIBN - INSP | 34% Loosely correlated | -2.09% | ||
More | ||||
| Ticker / NAME | Correlation To INSP | 1D Price Change % |
|---|---|---|
| INSP | 100% | -3.68% |
| challenging disorders theme (8 stocks) | 48% Loosely correlated | -0.11% |
| Medical Specialties theme (43 stocks) | 32% Poorly correlated | -0.49% |
| Medical Specialties theme (43 stocks) | 31% Poorly correlated | -0.49% |
| medical research theme (106 stocks) | 28% Poorly correlated | -1.58% |
| medical service theme (130 stocks) | 25% Poorly correlated | -1.30% |
More | ||
a developer of implantable neurostimulation systems to treat obstructive sleep apnea
Industry MedicalNursingServices
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where INSP declined for three days, in 249 of 319 cases, the price declined further within the following month. The odds of a continued downward trend are 78%.
The 10-day RSI Indicator for INSP moved out of overbought territory on September 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 20 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 67%.
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INSP as a result. In 64 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for INSP turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 33 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
INSP broke above its upper Bollinger Band on September 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 59 cases where INSP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The 50-day moving average for INSP moved above the 200-day moving average on September 30, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +7.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where INSP advanced for three days, in 231 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 146 of 199 cases where INSP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. INSP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 50 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.451) is normal, around the industry mean (10.930). P/E Ratio (15.453) is within average values for comparable stocks, (100.178). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.375) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INSP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.